Succinylcholine Versus Rocuronium for Emergency Intubation in Intensive Care
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00355368|
Recruitment Status : Completed
First Posted : July 21, 2006
Results First Posted : December 15, 2011
Last Update Posted : December 15, 2011
|Condition or disease||Intervention/treatment||Phase|
|Intubation||Drug: Succinylcholine Drug: Rocuronium||Phase 4|
Objective: to compare succinylcholine and rocuronium with regard to 1) quality of intubating conditions, 2) length of the intubating sequence, 3) failed intubating attempts, 4) hemodynamic sequelae of intubation, and 5) desaturations.
Design: prospective, randomized, single-blind study. Setting: Intensive care units of an University Hospital. Patients: adult patients in intensive care requiring emergency intubation. Randomization: 1:1 randomization to either succinylcholine (1mg/kg) or rocuronium (0.6 mg/kg).
Data: 1) assessment of the quality of intubating conditions by means of a score, 2) length of the intubating sequence defined as time between injection of neuromuscular blocking agent and first end-tidal CO2 on the monitor, 3) number of failed intubating attempts, 4) hemodynamic sequelae of intubation, defined as events requiring injection of vasoactive drugs, and 5) desaturations, defined as saturation below 90% and/or any decrease in saturation of 5% or more.
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||420 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Phase 4 Study of Succinylcholine Versus Rocuronium as Neuromuscular Blocking Agent for Emergency Intubation in Intensive Care|
|Study Start Date :||August 2006|
|Actual Primary Completion Date :||August 2006|
|Actual Study Completion Date :||July 2010|
|Active Comparator: Succinylcholine||
|Active Comparator: Rocuronium||
- Number of Participants Exhibiting Desaturation >5% [ Time Frame: at any time between the start of the intubation sequence and 2min after the completion of intubation ]decrease of >5% in oxygen saturation measured continuously using pulse oxymetry
- Haemodynamic Sequelae of Intubation [ Time Frame: between start of induction sequence and 5 min after completion of intubation ]any new haemodynamic alteration requiring immediate intervention
- Time to Completion of Intubation [ Time Frame: time interval between the injection of the induction agent and the first appearance of endtidal CO2 ]time interval between the injection of the induction agent and the first appearance of endtidal CO2
- Quality of Intubation Conditions Using a Validated Score: Viby-Mogensen et al. Good Clinical Research Practice (GCRP) in Pharmacodynamic Studies of Neuromuscular Blocking Agents. Acta Anaesthesiol Scand 1996;40:59-74. [ Time Frame: during laryngoscopy and the first minute after completion of intubation ]
The factors laryngoscopy, vocal cords, and response to intubation are individually rated with a score from 1 (bad intubation conditions)to 3 (excellent intubation conditions)and the resulting three scores are summed up. The maximum score is thus 9 while the minimum score is 3.
Units: measure on a scale
- Number of Participants With an Failed First Intubation Attempts [ Time Frame: within the first 90 sec following the start of induction ]defined as either uncompleted intubation attempt within 90 sec or starting a second intubation attempt
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00355368
|Department of Medical Intensive Care; University of Basel|
|Basel, BS, Switzerland, 4031|
|Principal Investigator:||Martin Siegemund, MD||Department of Surgical Intensive Care, University of Basel|
|Principal Investigator:||Stephan C Marsch, MD, DPhil||Department of Medical Intensive Care, University of Basel|